期刊文献+

三维适形放疗同步化疗对Ⅲ期NSCLC病人预后影响 被引量:2

INFLUENCE OF THREE DIMENSIONAL CONFORMAL RADIOTHERAPY COMBINED CHEMOTHERAPY ON PROGNOSIS OF PATIENTS WITH STAGE Ⅲ NON-SMALL CELL LUNG CANCER
下载PDF
导出
摘要 目的探讨术前三维适形放疗同步化疗对Ⅲ期非小细胞肺癌(NSCLC)病人预后的影响。方法以2007—2010年我院收治的术前行三维适形放疗同步化疗的Ⅲ期非小细胞肺癌病人49例作为观察组,直接手术病人47例作为对照组。比较两组手术切除率、术后并发症发生率及术后生存率的差异。结果观察组手术切除率显著高于对照组(χ2=4.304,P<0.05)。两组术后并发症发生率差异无显著性(P>0.05)。观察组1、3年生存率显著高于对照组(χ2=4.221、4.200,P<0.05)。结论术前三维适形放疗同步化疗可以显著提高Ⅲ期非小细胞肺癌的手术切除率及病人1、3年生存率,对术后并发症发生率无明显影响。 Objective To assess the effect of preoperative three dimensional conformal radiotherapy combined chemo-therapy (combined therapy) on the prognosis of patients with stage Ⅲ non-small cell lung cancer (NSCLC). Methods Forty-nine patients with stage Ⅲ NSCLC treated with the combined therapy before surgery during 2007--2010 were selected as observation group, and 47 underwent surgery without preoperative combined therapy served as a control group. A comparison was made between the two groups in terms of resection rate, post-operative complications and post-operative survival. Results The resection rate in the observation group was higher than that in the control grou (X 2 = 4.304, P ~0.05). The post-operative complications were not significantly different between the two groups (P〉0.05). The one-year and three-year survival rates were higher in the observation group than the control group (X 2= 4.221,4. 200 ; P〈0.05). Conclusion Preoperative three dimensional conformal radiotherapy combined chemotherapy can significantly increase the resection rate, one-and three-year survival rates of patients with stage Ⅲ NSCLC, which does not affect post-operative complications.
出处 《齐鲁医学杂志》 2015年第2期147-148,151,共3页 Medical Journal of Qilu
关键词 非小细胞肺 放射疗法 适形 药物疗法 预后 carcinoma, non-small-cell lung radiotherapy, conformal drag therapy prognosis
  • 相关文献

参考文献12

二级参考文献91

共引文献66

同被引文献27

  • 1夏邦世,吴金华.Kappa一致性检验在检验医学研究中的应用[J].中华检验医学杂志,2006,29(1):83-84. 被引量:214
  • 2SIEGEL R,DESANTIS C,JEMAL A.Colorectal cancer sta- tistics,2014[J],CA-A Cancer Journal for Clinicians,2014,64(2):104-117. 被引量:1
  • 3MCELNAY P, LIM E.Adjuvant or neoadjuvant chemothera- py for NSCLC[J].Journal of Thoracic Disease,2014,6(Suppl 1):1S-10S. 被引量:1
  • 4KHOKHER S,QURESHI M U,CHAUDHRY N A.Com- parison of WHO and RECIST criteria for evaluation of clinical response to chemotherapy in patients with advanced breast cancer[J].Asian Pacific Journal of Cancer Prevention:APJCP'2012,13(7):3213-3218. 被引量:1
  • 5WEBER W A.Assessing tumor response to therapy[J].Jour- nal of Nuclear Medicine,2009,50(Suppl 2):S224-S227. 被引量:1
  • 6KHOKHER S,QURESHI M U,CHAUDHRY N A.Com- parison of WHO and RECIST criteria for evaluation of clinical response to chemotherapy in patients with advanced breast cancer[J].Asian Pacific Journal of Cancer Prevention:APJCP,2012,13(7);3213-3218. 被引量:1
  • 7THERASSE,European Organisation for Research and Treat- ment of Cancer Data Center.Evaluation of response:new and standard criteria[J],Ann Oncol,2002,13(Suppl 4):127-129. 被引量:1
  • 8ROCKALL A G,AVRIL N,LAM R,et al.Repeatability of quantitative FDG-PET/CT and contrast-enhanced CT in recur- rent ovarian carcinoma:test-retest measurements for tumor FDG uptake,diameter,and volume[J].Clinical Cancer Re- search:an Official Journal of the American Association for Cancer Research,2014,20(10):2751-2760. 被引量:1
  • 9Lohia S,Rajapurkar M,Nguyen SA,et al. A comparison of outcomes using intensity-modulated radiation therapy and 3-dimensional conformal radiation therapy in treatment of oropharyngeal cancer[J]. JAMA Otolaryngol Head Neck Surg, 2014,140(4) : 331-337. 被引量:1
  • 10Adas YG,Andrieu MN,Hicsonmez A,et al. Comparison of 2-dimensional and 3-dimensional conforrnal treatment plans in gastric cancer radiotherapy[J]. Asian Pac J Cancer Prey, 2014,15 (17) : 7401-7405. 被引量:1

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部